Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/60/e8/af/60e8af10-bdff-df62-65d2-b67a544373d1/mza_13084884134369712645.jpg/600x600bb.jpg
The NRG Oncology Podcast
NRG Oncology
33 episodes
1 week ago
The NRG Oncology Podcast, developed by NRG Oncology, is hosted by Drs. Stephen Chun and Lauren Henke. Stephen and Lauren delve into a variety of topics impacting the oncology community via interviews with various stakeholders throughout the NRG Oncology organization.
Show more...
Medicine
Health & Fitness
RSS
All content for The NRG Oncology Podcast is the property of NRG Oncology and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The NRG Oncology Podcast, developed by NRG Oncology, is hosted by Drs. Stephen Chun and Lauren Henke. Stephen and Lauren delve into a variety of topics impacting the oncology community via interviews with various stakeholders throughout the NRG Oncology organization.
Show more...
Medicine
Health & Fitness
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/41380161/41380161-1748532317893-a0ac45f47d6c9.jpg
The NRG-BR003 Results in Triple-Negative Breast Cancer
The NRG Oncology Podcast
32 minutes 3 seconds
5 months ago
The NRG-BR003 Results in Triple-Negative Breast Cancer

Our co-hosts discuss triple-negative breast cancer in light of the recently presented results at the 2025 ASCO Annual Meeting. We interview Dr. Vicente Valero, the NRG-BR003 PI, and Dr. Julie Gralow, the Chief Medical Officer of ASCO about these findings and current research in breast cancer.

The NRG Oncology Podcast
The NRG Oncology Podcast, developed by NRG Oncology, is hosted by Drs. Stephen Chun and Lauren Henke. Stephen and Lauren delve into a variety of topics impacting the oncology community via interviews with various stakeholders throughout the NRG Oncology organization.